These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 28964581)

  • 21. Factors associated with the development of exudation in treatment-naive eyes with nonexudative macular neovascularization.
    Cho HJ; Kim M; Kim J; Yoon I; Park S; Kim CG
    Graefes Arch Clin Exp Ophthalmol; 2024 Jul; 262(7):2073-2082. PubMed ID: 38349420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CUTICULAR DRUSEN: Risk of Geographic Atrophy and Macular Neovascularization.
    Sakurada Y; Parikh R; Gal-Or O; Balaratnasingam C; Leong BCS; Tanaka K; Cherepanoff S; Spaide RF; Freund KB; Yannuzzi LA
    Retina; 2020 Feb; 40(2):257-265. PubMed ID: 31972795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative Assessment of Choriocapillaris Flow Deficits in Eyes with Advanced Age-Related Macular Degeneration Versus Healthy Eyes.
    Alagorie AR; Verma A; Nassisi M; Sadda SR
    Am J Ophthalmol; 2019 Sep; 205():132-139. PubMed ID: 31078531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drusen Volume as a Predictor of Disease Progression in Patients With Late Age-Related Macular Degeneration in the Fellow Eye.
    Abdelfattah NS; Zhang H; Boyer DS; Rosenfeld PJ; Feuer WJ; Gregori G; Sadda SR
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1839-46. PubMed ID: 27082298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural OCT Signs Suggestive of Subclinical Nonexudative Macular Neovascularization in Eyes with Large Drusen.
    Narita C; Wu Z; Rosenfeld PJ; Yang J; Lyu C; Caruso E; McGuinness M; Guymer RH
    Ophthalmology; 2020 May; 127(5):637-647. PubMed ID: 31899036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimodal Imaging Features and Clinical Relevance of Subretinal Lipid Globules.
    Fernández-Avellaneda P; Freund KB; Wang RK; He Q; Zhang Q; Fragiotta S; Xu X; Ledesma-Gil G; Sugiura Y; Breazzano MP; Yannuzzi LA; Liakopoulos S; Sarraf D; Dolz-Marco R
    Am J Ophthalmol; 2021 Feb; 222():112-125. PubMed ID: 32918902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of Nonexudative Macular Neovascularization on Structural OCT Images Using Vision Transformers.
    Kihara Y; Shen M; Shi Y; Jiang X; Wang L; Laiginhas R; Lyu C; Yang J; Liu J; Morin R; Lu R; Fujiyoshi H; Feuer WJ; Gregori G; Rosenfeld PJ; Lee AY
    Ophthalmol Sci; 2022 Dec; 2(4):100197. PubMed ID: 36531577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nascent Geographic Atrophy as a Predictor of Type 3 Macular Neovascularization Development.
    Sacconi R; Sarraf D; Sadda SR; Freund KB; Servillo A; Fogel Levin MM; Costanzo E; Corradetti G; Cabral D; Zur D; Trivizki O; Parravano M; Bandello F; Loewenstein A; Querques G
    Ophthalmol Retina; 2023 Jul; 7(7):586-592. PubMed ID: 36736896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Swept-Source OCT Angiographic Characteristics of Treatment-Naïve Nonexudative Macular Neovascularization in AMD Prior to Exudation.
    Shen M; Zhang Q; Yang J; Zhou H; Chu Z; Zhou X; Feuer W; Jiang X; Shi Y; de Sisternes L; Durbin MK; Wang RK; Gregori G; Rosenfeld PJ
    Invest Ophthalmol Vis Sci; 2021 May; 62(6):14. PubMed ID: 33984121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optical Coherence Tomography Angiography Quantitative Assessment of Macular Neovascularization in Best Vitelliform Macular Dystrophy.
    Parodi MB; Arrigo A; Bandello F
    Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):61. PubMed ID: 32602906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrahigh-Speed, Swept-Source Optical Coherence Tomography Angiography in Nonexudative Age-Related Macular Degeneration with Geographic Atrophy.
    Choi W; Moult EM; Waheed NK; Adhi M; Lee B; Lu CD; de Carlo TE; Jayaraman V; Rosenfeld PJ; Duker JS; Fujimoto JG
    Ophthalmology; 2015 Dec; 122(12):2532-44. PubMed ID: 26481819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SPATIAL DISTRIBUTION OF CHORIOCAPILLARIS IMPAIRMENT IN EYES WITH CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION: A Quantitative OCT Angiography Study.
    Moult EM; Alibhai AY; Rebhun C; Lee B; Ploner S; Schottenhamml J; Husvogt L; Baumal CR; Witkin AJ; Maier A; Duker JS; Rosenfeld PJ; Waheed NK; Fujimoto JG
    Retina; 2020 Mar; 40(3):428-445. PubMed ID: 31415449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of macular neovascularization lesion size by the use of Spectral-Domain Optical Coherence Tomography Angiography and Swept-Source Optical Coherence Tomography Angiography versus Indocyanine Green Angiography.
    Haas AM; Ahmed D; Stattin M; Graf A; Krepler K; Ansari-Shahrezaei S
    Acta Ophthalmol; 2021 Mar; 99(2):e260-e266. PubMed ID: 32833284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optical coherence tomography angiography for the detection of macular neovascularization-comparison of en face versus cross-sectional view.
    Siggel R; Spital C; Lentzsch A; Liakopoulos S
    Eye (Lond); 2023 Feb; 37(2):256-262. PubMed ID: 34992250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonexudative Macular Neovascularization Supporting Outer Retina in Age-Related Macular Degeneration: A Clinicopathologic Correlation.
    Chen L; Messinger JD; Sloan KR; Swain TA; Sugiura Y; Yannuzzi LA; Curcio CA; Freund KB
    Ophthalmology; 2020 Jul; 127(7):931-947. PubMed ID: 32247535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rediscovering Age-Related Macular Degeneration with Swept-Source OCT Imaging: The 2022 Charles L. Schepens, MD, Lecture.
    Rosenfeld PJ; Shen M; Trivizki O; Liu J; Herrera G; Hiya FE; Li J; Berni A; Wang L; El-Mulki OS; Cheng Y; Lu J; Zhang Q; O'Brien RC; Gregori G; Wang RK
    Ophthalmol Retina; 2024 Sep; 8(9):839-853. PubMed ID: 38641006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY PARAMETER VARIATIONS AFTER TREATMENT OF MACULAR NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
    Arrigo A; Aragona E; Bordato A; Amato A; Borghesan F; Bandello F; Parodi MB
    Retina; 2021 Jul; 41(7):1463-1469. PubMed ID: 33315820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PREDICTIVE ACTIVATION BIOMARKERS OF TREATMENT-NAIVE ASYMPTOMATIC CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION.
    Serra R; Coscas F; Boulet JF; Cabral D; Lupidi M; Coscas GJ; Souied EH
    Retina; 2020 Jul; 40(7):1224-1233. PubMed ID: 31259809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Drusen and Hyperreflective Foci as Biomarkers for Disease Progression in Age-Related Macular Degeneration Using Artificial Intelligence in Optical Coherence Tomography.
    Waldstein SM; Vogl WD; Bogunovic H; Sadeghipour A; Riedl S; Schmidt-Erfurth U
    JAMA Ophthalmol; 2020 Jul; 138(7):740-747. PubMed ID: 32379287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Choroidal Changes After Anti-VEGF Therapy in AMD Eyes With Different Types of Macular Neovascularization Using Swept-Source OCT Angiography.
    Shen M; Zhou H; Lu J; Li J; Jiang X; Trivizki O; Laiginhas R; Liu J; Zhang Q; de Sisternes L; Feuer WJ; O'Brien R; Gregori G; Wang RK; Rosenfeld PJ
    Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):16. PubMed ID: 37819744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.